Micaela Dawson

Digesting Digital Medicine: Healthcare Benefits When Smart Pills Track When Taken

/0 Comments/in , /by Micaela Dawson
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Host Joe Selvaggi and Pioneer Institute’s Bill Smith talk with Valerie Sullivan, President and CEO of EtectRX about the health care costs of improperly taking prescriptions and the promise of smart pills to signal and track medicines when ingested.

Guest:

Valerie Sullivan is President and CEO of etectRX where she is passionate about creating meaningful, cost-effective solutions across the healthcare ecosystem by leveraging patient engagement and digital technology to support greater outcomes, more therapeutic impact and the?potential to serve an unmet need. Prior to joining etectRx, she served as President of InVentiv Patient Access Solutions (sold to Xerox in 2015), a tech-enabled patient support services company. In addition, she served as Vice President and General Manager of the Patient Service Center at Pear Therapeutics, a program that she envisioned and built from the ground up. She began her career in healthcare working at Pfizer for over 15 years. Ms. Sullivan serves as an independent member on the board of directors at CareMetx and Two Labs Pharma Services. As well, she is Chairman at the Group Insurance Commission, a quasi-state agency in the Commonwealth of MA. She is on faculty at Bentley University as adjunct professor in the Management Department. Ms. Sullivan holds a Bachelor of Arts in Chemistry and Economics from College of the Holy Cross in Worcester, Massachusetts, and an MBA in Finance and Marketing from Northeastern University.

Get new episodes of Hubwonk in your inbox!

Recent episodes:

Poor Housing Incentives: Tax Credits Reward Politicians Not Neighbors in Need

Joe Selvaggi interviews Chris Edwards, Chair of Fiscal Studies at CATO Institute, about his research on the 40-year history of Low-Income Housing Tax Credits. They delve into its features, effects, and potential alternatives that could provide greater benefits at lower costs to taxpayers.

Biden’s Budget Breakdown: Pragmatic Progress or Political Posturing

Joe Selvaggi talks with Manhattan Institute Senior Fellow Brian Reidl about how the contours of President Biden’s recently released budget proposal reveal a persistent, bipartisan reluctance to address profound structural deficits.

Genetic Therapy Revolution: Benefits and Barriers for Medicine’s New Horizon

Joe Selvaggi talks with neurobiologist and writer Dr. Anne Sydor about the potential for gene therapy to address deadly and debilitating diseases and how current health care models must adapt to encourage this nascent technology.

Contours of Content Curation: SCOTUS Hears Online Free Speech Cases

Cato Institute's Thomas Berry, talks about oral arguments at the Supreme Court in the NetChoice cases, exploring the First Amendment questions that affect both social media users and the platforms that curate their content.

Mortgage’s New Normal: Guide to Better Borrowing Amidst Higher Rates

Joe Selvaggi talks with mortgage expert, Trip Miller of Cambridge Savings Bank, about mortgage rates and trends and explores best practices for finding a mortgage structure that suits individual buyers’ needs.

Medicaid’s Massive Miasma: Taming Beacon Hill’s Burgeoning Budget Beast

Marc Joffe, a state policy analyst at the Cato Institute, talks about his research on Medicaid's cost and size. They explore how Massachusetts can control spending growth while protecting other priorities.

Baystate Budget Blues: Declining Revenue Causes Concern

Joe Selvaggi engages in a conversation with Pioneer Institute’s Eileen McAnneny, Senior Fellow for Economic Opportunity, to analyze the status of the 2024 budget. They compare actual revenue and spending with pre-July 1 estimates, investigating potential reasons for any surpluses or shortfalls. They also dive into policy implications for legislators as they approach fiscal 2025.

Smothering Gas Exports: President Sides with Environmentalists Over Environment

Dr. Benjamin Zycher, a senior fellow at the American Enterprise Institute, talks on the impact of President Biden's executive order to halt liquefied natural gas export approvals. He explores potential economic impacts, the response from trading partners, and the negligible effect on climate.

U.S. Manufacturing Health: Does the U.S. Need an Industrial Policy?

Scott Lincicome from the Cato Institute discusses the U.S. manufacturing industry, international trade, and industrial policy. He dispels the myth of manufacturing decline, highlighting sector evolution and productivity. The conversation moves to industrial policy, emphasizing the need for targeted protection and cautioning against broad subsidization due to potential inefficiencies.

Challenging Government Prerogatives: SCOTUS Reconsiders Deference to Executive Agencies

Joe Selvaggi engages in a conversation with legal scholar Ilya Shapiro from the Manhattan Institute regarding the Loper Bright Enterprises Supreme Court case that questions the Chevron Doctrine. This doctrine instructs judges to defer to government agencies in situations where laws are silent or unclear.

Harvard’s Sullied Halo: Journalists Teach Lesson on Plagiarism

Joe Selvaggi talks with investigative reporter Chris Brunet about his role investigating and exposing former Harvard President Claudine Gay’s academic plagiarism, a story that lead to her eventual resignation.

Drug Discount Distortions: How Middlemen Increase Costs and Reduce Access

Joe Selvaggi talks with Drs. Bill Smith and Robert Popovian about how the complex system of rebates from drug companies to insurance firms serve to increase costs and reduce access for patients.